LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Tozasertib | 0.37 | uM | LJP5 | 2 | B16 | 72 | hr | 962 | 1327 | 10507 | 0.1263 | 0.0977 |
MCF 10A | Tozasertib | 0.37 | uM | LJP5 | 3 | B16 | 72 | hr | 962 | 1339 | 10315 | 0.1298 | 0.1014 |
MCF 10A | Tozasertib | 1.11 | uM | LJP5 | 1 | B15 | 72 | hr | 962 | 1441 | 10714 | 0.1345 | 0.1232 |
MCF 10A | Tozasertib | 1.11 | uM | LJP5 | 2 | B15 | 72 | hr | 962 | 1234 | 10507 | 0.1174 | 0.0748 |
MCF 10A | Tozasertib | 1.11 | uM | LJP5 | 3 | B15 | 72 | hr | 962 | 1493 | 10315 | 0.1447 | 0.1370 |
MCF 10A | Tozasertib | 3.33 | uM | LJP5 | 1 | B14 | 72 | hr | 962 | 1385 | 10714 | 0.1293 | 0.1105 |
MCF 10A | Tozasertib | 3.33 | uM | LJP5 | 2 | B14 | 72 | hr | 962 | 1242 | 10507 | 0.1182 | 0.0768 |
MCF 10A | Tozasertib | 3.33 | uM | LJP5 | 3 | B14 | 72 | hr | 962 | 1419 | 10315 | 0.1376 | 0.1202 |
MCF 10A | Tozasertib | 10 | uM | LJP5 | 1 | B13 | 72 | hr | 962 | 1309 | 10714 | 0.1222 | 0.0926 |
MCF 10A | Tozasertib | 10 | uM | LJP5 | 2 | B13 | 72 | hr | 962 | 1197 | 10507 | 0.1139 | 0.0654 |
MCF 10A | Tozasertib | 10 | uM | LJP5 | 3 | B13 | 72 | hr | 962 | 1294 | 10315 | 0.1255 | 0.0904 |
MCF 10A | Imatinib | 0.04 | uM | LJP6 | 1 | N18 | 72 | hr | 962 | 10847 | 10693 | 1.0143 | 1.0082 |
MCF 10A | Imatinib | 0.04 | uM | LJP6 | 2 | N18 | 72 | hr | 962 | 10611 | 10740 | 0.9879 | 0.9930 |
MCF 10A | Imatinib | 0.04 | uM | LJP6 | 3 | N18 | 72 | hr | 962 | 10683 | 10641 | 1.0039 | 1.0022 |
MCF 10A | Imatinib | 0.12 | uM | LJP6 | 1 | N17 | 72 | hr | 962 | 10665 | 10693 | 0.9973 | 0.9985 |
MCF 10A | Imatinib | 0.12 | uM | LJP6 | 2 | N17 | 72 | hr | 962 | 10954 | 10740 | 1.0199 | 1.0113 |
MCF 10A | Imatinib | 0.12 | uM | LJP6 | 3 | N17 | 72 | hr | 962 | 10588 | 10641 | 0.9950 | 0.9971 |
MCF 10A | Imatinib | 0.37 | uM | LJP6 | 1 | N16 | 72 | hr | 962 | 10790 | 10693 | 1.0090 | 1.0052 |
MCF 10A | Imatinib | 0.37 | uM | LJP6 | 2 | N16 | 72 | hr | 962 | 10606 | 10740 | 0.9875 | 0.9928 |
MCF 10A | Imatinib | 0.37 | uM | LJP6 | 3 | N16 | 72 | hr | 962 | 10490 | 10641 | 0.9858 | 0.9917 |
MCF 10A | Imatinib | 1.11 | uM | LJP6 | 1 | N15 | 72 | hr | 962 | 10766 | 10693 | 1.0068 | 1.0039 |
MCF 10A | Imatinib | 1.11 | uM | LJP6 | 2 | N15 | 72 | hr | 962 | 10564 | 10740 | 0.9835 | 0.9905 |
MCF 10A | Imatinib | 1.11 | uM | LJP6 | 3 | N15 | 72 | hr | 962 | 10251 | 10641 | 0.9633 | 0.9785 |
MCF 10A | Imatinib | 3.33 | uM | LJP6 | 1 | N14 | 72 | hr | 962 | 10787 | 10693 | 1.0087 | 1.0050 |
MCF 10A | Imatinib | 3.33 | uM | LJP6 | 2 | N14 | 72 | hr | 962 | 10839 | 10740 | 1.0091 | 1.0052 |